亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Summarizing historical information on controls in clinical trials

样本量测定 临床试验 统计 样品(材料) 随机对照试验 计算机科学 计量经济学 医学 数学 内科学 化学 色谱法
作者
Beat Neuenschwander,Gorana Capkun-Niggli,Michael Branson,David J. Spiegelhalter
出处
期刊:Clinical Trials [SAGE Publishing]
卷期号:7 (1): 5-18 被引量:294
标识
DOI:10.1177/1740774509356002
摘要

Historical information is always relevant when designing clinical trials, but it might also be incorporated in the analysis. It seems appropriate to exploit past information on comparable control groups.Phase IV and proof-of-concept trials are used to discuss aspects of summarizing historical control data as prior information in a new trial. The importance of a fair assessment of the similarity of control parameters is emphasized.The methodology is meta-analytic-predictive. Heterogeneity of control parameters is expressed via the between-trial variation, which is the key parameter determining the prior effective sample size and its upper bound (prior maximum sample size).For a Phase IV trial (930 control patients in 11 historical trials) between-trial heterogeneity was fairly small, resulting in a prior effective sample size of approximately 90 patients. For a proof-of-concept trial (363 patients in four historical trials) heterogeneity was moderate to substantial, resulting in a prior effective sample size of approximately 20. For another proof-of-concept trial (14 patients in one historical trial), assuming substantial heterogeneity implied a prior effective sample size of 7. The prior effective sample size can only be large if the amount of historical data is large and between-trial heterogeneity is small. The prior effective sample size is bounded by the prior maximum sample size (ratio of within- to between-trial variance), irrespective of the amount of historical data.The meta-analytic-predictive approach assumes exchangeability of control parameters across trials. Due to the difficulty to quantify between-trial variability, sensitivity of conclusions regarding assumptions and type of inference should be assessed.The use of historical control information is a valuable option and may lead to more efficient clinical trials. The proposed approach is attractive for nonconfirmatory trials, but under certain circumstances extensions to the confirmatory setting could be envisaged as well.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
FashionBoy的应助被闪闪婴采纳,获得10
4秒前
lsc完成签到,获得积分10
5秒前
小fei完成签到,获得积分10
11秒前
麻辣薯条完成签到,获得积分10
17秒前
科研通AI6.4的应助被闪闪婴采纳,获得30
18秒前
时尚身影完成签到,获得积分10
23秒前
leoduo完成签到,获得积分0
30秒前
30秒前
天天快乐的应助被闪闪婴采纳,获得10
32秒前
Rain发布了新的文献求助10
34秒前
跳跃的枫完成签到,获得积分10
35秒前
流苏2完成签到,获得积分10
36秒前
斯文败类的应助被科研通管家采纳,获得10
38秒前
舒适曼文完成签到,获得积分10
40秒前
科研通AI6.2的应助被闪闪婴采纳,获得10
45秒前
48秒前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
簪星曳月完成签到,获得积分10
1分钟前
1分钟前
缓慢的映天完成签到,获得积分10
1分钟前
大胆醉卉完成签到,获得积分10
1分钟前
丘比特的应助被闪闪婴采纳,获得10
1分钟前
YCYycy完成签到,获得积分10
1分钟前
1分钟前
嘟嘟嘟完成签到,获得积分10
1分钟前
科目三的应助被小小采纳,获得10
2分钟前
专注的小白菜完成签到,获得积分10
2分钟前
Rachel完成签到,获得积分10
2分钟前
英姑的应助被Manana采纳,获得30
2分钟前
Candy完成签到 ,获得积分10
2分钟前
可靠的靖巧完成签到,获得积分10
2分钟前
希望天下0贩的0的应助被小小采纳,获得10
2分钟前
2分钟前
科研通AI6.2的应助被尊嘟假嘟采纳,获得10
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Aspects of Post-SPE Phonology 2000
CLSI VET01S Ed7 Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals 1000
Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals 888
Rosenblum, Global Change Biology 800
Holistic Discourse Analysis, Second Edition by Robert E. Longacre (2012-09-10) 666
Berberine regulates the TLR4 signaling pathway to suppress hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells 530
热门求助领域 (近24小时)
化学 材料科学 医学 生物 计算机科学 工程类 纳米技术 物理 有机化学 化学工程 内科学 生物化学 复合材料 催化作用 心理学 细胞生物学 无机化学 电极 光电子学 人工智能
热门帖子
关注 科研通微信公众号,转发送积分 7864949
求助须知:如何正确求助?哪些是违规求助? 9382446
关于积分的说明 20735970
捐赠科研通 7465325
什么是DOI,文献DOI怎么找? 3348875
关于科研通互助平台的介绍 2490153
邀请新用户注册赠送积分活动 2374102